Lead Product(s) : TFC-1326
Therapeutic Area : Dermatology
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Sirona Biochem Initiates GlycoProteMim Trademark for Anti-Aging Molecule TFC-1326
Details : GlycoProteMim (TFC-1326) is Sirona’s lead anti-aging compound, a topical cream small molecule drug candidate, with potential to reverse the effects of aging on facial skin, restoring lost volume and reducing fine wrinkles.
Product Name : TFC-1326
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
November 12, 2023
Lead Product(s) : TFC-1326
Therapeutic Area : Dermatology
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : TFC-1326
Therapeutic Area : Dermatology
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Sirona Biochem Announces Start of Clinical Trial for Anti-Aging Compound TFC-1326
Details : The formulation is a cream base with TFC-1326 at a concentration of 1% and no other active ingredients. The trial is designed to assess the compound’s efficacy in reversing aging facial skin, including restoring lost volume (plumping) and reducing fine...
Product Name : TFC-1326
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
August 12, 2022
Lead Product(s) : TFC-1326
Therapeutic Area : Dermatology
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Cannabinoid,MicroSilver BG
Therapeutic Area : Dermatology
Study Phase : Phase I
Sponsor : Bio-Gate AG
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Bio-Gate is developing active cosmetic and dermatology products in collaboration with Avicanna that combine MicroSilver BG™ and CBD (hemp derived) to deliver synergistic anti-inflammatory and antimicrobial effects.
Product Name : re+PLAY
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
June 29, 2021
Lead Product(s) : Cannabinoid,MicroSilver BG
Therapeutic Area : Dermatology
Highest Development Status : Phase I
Sponsor : Bio-Gate AG
Deal Size : Inapplicable
Deal Type : Inapplicable